Skip to main content
Clinical Trials/NCT02331069
NCT02331069UnknownNot Applicable

Delto-Tricipital Compression Syndrome: A Randomized Treatment Comparison Trial of Dextrose Injection Versus Physical Therapy.

Universidad Abierta Interamericana2 sites in 1 country80 target enrollmentStarted: January 2015Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
80
Locations
2
Primary Endpoint
NRS Pain (0-10 Numerical Rating Scale)

Study Overview

Brief Summary

The posterior antebrachial cutaneous nerve (PACN) can be compressed between the deltoid and triceps, with resultant pain and dysfunction. The active treatment for this study will be injection of the point of compression and along the painful course of the sensory nerve with 5% dextrose. The control treatment will be physical therapy.

Detailed Description

The PACN is a purely sensory nerve that originates in the midforearm, courses anterior to the lateral epicondyle, and travels proximally until it dives between the posterior portion of the V shaped insertion of the deltoid and the external? insertion of the triceps, whereupon it joins with the radial nerve.

A proposed pathological explanation is that repetitive co-contraction produces irritation and compression of the nerve at the delto-tricipital (D-T) fascial penetration point. Clinically the patient experiences pain localized to that compression point, and traveling distally along the course of some or all of the posterior femoral cutaneous nerve.

Perineural injection of dextrose has been previously reported for therapeutic use in chronic pain associated with Achilles tendinopathy. Empirically,injection of D5W with a small needle along the course of the PACN and at the D-T penetrator has been found to resolve both pain and dysfunction (describe dysfunction).

Participants will be randomly assigned to either 1 month of physical therapy or to 0,1,2 and 3 week injection of D5W. The use of standardized measurement tools for pain (0-10 numerical rating scale) and function (Quick DASH) will be utilized to determine baseline status and status at 1 month. At 1 month, subjects receiving therapy will be allowed to cross over to injection treatment and all participants will receive as needed treatment until the 1 year period of follow-up. Thus only 1 month data is randomized but long term data will be gathered.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Pain in the deltotricipital groove,extending down the lateral septum.
  • Pain rating 6 or more on a 0-10 numerical rating scale (NRS)
  • Reproduction of pain with provocative maneuvers. Lifting a 6 pound weight to 60 degrees with the below at 40 degrees of elbow extension and the clinician creating a flexion force on the elbow which the participant resists. (Need a picture)
  • Pain more than 3 months?

Exclusion Criteria

  • Pain in other arm or shoulder locations on either side more than 2/10
  • Pain in other part of the body more than 4/
  • Taking narcotics for pain.
  • Pain with testing of shoulder laxity.
  • Massive rupture of rotator cuff (complete width tear) evidenced by examination or MRI scan.
  • Level III-IV or more shoulder arthritis on plain film of shoulder.
  • Other peripheral neuropathy.
  • Unstable psychiatric status

Arms & Interventions

Dextrose 5% (D5W) Injection

Active Comparator

Glucose injection in 5% concentration, administered weekly X 4 times in a volume of 12 ml or less.

Intervention: Dextrose 5% (D5W) (Drug)

Physical Therapy

Active Comparator

Physical therapy for a month in the posterior deltoid region 3 times a week.

Intervention: Physical therapy (Other)

Outcomes

Primary Outcomes

NRS Pain (0-10 Numerical Rating Scale)

Time Frame: Time 0 and 1 month

0-10 Numerical Rating Scale for pain.

Secondary Outcomes

  • Quick Dash Score(Time 0 and 1 month)

Investigators

Sponsor
Universidad Abierta Interamericana
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Miguel Slullitel

Professor of Orthopedic Surgery

Universidad Abierta Interamericana

Study Sites (2)

Loading locations...

Similar Trials

Completed
Phase 3
The Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) 3.0 Randomized single-blind controlled trial of conservative treatment by local injection therapy (with or without corticosteroids) for entrapment of the anterior intercostal cutaneous nerve through the rectus abdominis muscle.buikwandpijnsyndroomThe Anterior Cutaneous Nerve Entrapment Syndrome (ACNES). Chronic abdominal wall pain
NL-OMON39921Maxima Medisch Centrum136
Completed
Not Applicable
The Anterior Cutaneous Nerve Entrapment Syndrome (ACNES). Retrograde transforaminal paresthesia mapping (RTPM) for patients with ACNES. A pilot study for the anatomical distribution of neuropathic pain in the trunk at the level of the dorsal root ganglion.entrapped nerve abdominal wall1003460610009720intercostal neuralgia
NL-OMON42590Maxima Medisch Centrum20
Completed
Not Applicable
The Anterior Cutaneous Nerve Entrapment Syndrome (ACNES).Randomized controlled trial of conservative treatment by local injection therapy with or without use of ultrasound for entrapment of the anterior intercostal cutaneous nerve through the rectus abdominis muscle.Anterior Cutaneous Nerve Entrapment Syndrome (ACNES).
NL-OMON23723o sponsor190
Recruiting
Not Applicable
The Anterior Cutaneus Nerve Entrapment Syndrome (ACNES). A Randomized double blind controlled trial for the diagnosis and treatment of entrapment of the anterior cutaneus nerve through the rectus muscle.
NL-OMON26786Performer: drs. O.B.A. Boelens44
Completed
Not Applicable
The anterior cutaneus nerve entrapment syndrome (ACNES). Randomized double blind controlled trial for the diagnosis and treatment of entrapment of the anterior cutaneus nerve through the rectus muscle.abdominal wall nerve entrapmentACNES1003460610040795
NL-OMON32058Máxima Medisch Centrum44